quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:02:45·715d
NEWSRelease
DoubleVerify Holdings Inc. logo
Innodata Inc. logo
iSun Inc. logo
+4

Nasdaq Down Over 50 Points; Uber Posts Q1 Loss

DV· DoubleVerify Holdings Inc.INOD· Innodata Inc.ISUN· iSun Inc.MCRB· Seres Therapeutics Inc.REBN· Reborn Coffee Inc.TMCI· Treace Medical Concepts Inc.
TechnologyHealth CareConsumer Discretionary
Original source

Companies

  • DV
    DoubleVerify Holdings Inc.
    Technology
  • INOD
    Innodata Inc.
    Technology
  • ISUN
    iSun Inc.
    Technology
  • MCRB
    Seres Therapeutics Inc.
    Health Care
  • REBN
    Reborn Coffee Inc.
    Consumer Discretionary
  • TMCI
    Treace Medical Concepts Inc.
    Health Care
  • UBER
    Uber Technologies Inc.
    Real Estate

Recent analyst ratings

  • Feb 4UBERUpdateCitizens JMP$100.00
  • Jan 14UBERUpdateBNP Paribas Exane$108.00
  • Jan 12DVUpdateBarclays$12.00
  • Jan 5INODUpdateBWS Financial$110.00
  • Jan 5UBERUpdateMelius$73.00
  • Dec 5UBERUpdateErste Group-

Related

  • PR16h
    DoubleVerify First Measurement Provider to Earn MRC Accreditation for TikTok Video Viewability Reporting
  • PR16h
    Reborn Coffee Provides Full Year 2025 Corporate Update and Financial Results
  • PR1d
    Federal Jury Once Again Finds Uber Responsible for Driver Assault at Second Consecutive Bellwether Trial, Awarding Damages to North Carolina Plaintiff
  • SEC1d
    SEC Form 10-K filed by Reborn Coffee Inc.
  • PR1d
    Coco Robotics Launches with Uber Eats in San Jose, Expanding Autonomous Delivery Across the U.S.
  • PR1d
    Uber and Block Expand Global Partnership to Transform Restaurant Operations and Launch Cash App Pay
  • SEC2d
    Reborn Coffee Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
  • INSIDER3d
    SEC Form 4 filed by Hair Mark
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022